Loading stock data…
¥6,040-130.00 (-2.11%)
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
Chugai Pharmaceutical Co., Ltd. in the Healthcare sector is trading at ¥6,040 with a market capitalization of $11.1T. Wall Street consensus targets ¥8,677 (15 analysts), implying a +43.7% move over the next 12 months. The stock is currently near its 52-week low of ¥5,974, remaining 23.0% below its 200-day moving average. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (JPY) · Annual | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total Revenue | ¥1.26T↑ | ¥1.11T↓ | ¥1.17T↓ | ¥1.26T |
| Gross Profit | ¥783.48B↑ | ¥698.06B↓ | ¥831.20B↓ | ¥894.25B |
| Operating Income | ¥533.31B↑ | ¥439.17B↓ | ¥542.00B↓ | ¥598.83B |
| Net Income | ¥374.43B↑ | ¥325.47B↓ | ¥387.32B↓ | ¥434.01B |
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Ava...